Abstract:Background We aimed to elucidate the causal relationship between plasma metabolites and the vulnerability to Osteoarthritis (OA), encompassing both hip OA and knee OA. Methods We conducted a two-way two-sample Mendelian randomization (MR) analysis to investigate the association of 1,400 plasma metabolites with OA. The Inverse Variance Weighted (IVW) model served as the primary two-sample MR Analysis method, with supplementary analysis using the Weighted Median (WM) and MR Egger methods. To ensure the robustness of our findings, sensitivity analyses were performed, incorporating Cochran’s Q test, MR-Egger intercept test, MR-PRESSO, and Leave-One-Out analyses. To validate the identified metabolites, we utilized the Steiger test and linkage disequilibrium score regression. Results A total of 94 plasma metabolites were associated with osteoarthritis, with 60 associated with hip OA and 106 associated with knee OA. IVW analysis revealed that tryptophan levels showed the strongest positive association with hip OA (OR [95% CI]: 1.119 [1.024, 1.223]), while X-24757 levels exhibited the highest positive association with knee osteoarthritis (OR [95% CI]: 1.095 [1.032, 1.162]). Ethylparaben sulfate levels were found to have the greatest positive association with hip OA (OR [95% CI]: 1.118 [1.015, 1.231]). Notably, the plasma metabolite X-2475 showed a strong robust random effect across all three types of osteoarthritis. Metabolic pathway analysis revealed that the pathogenesis of osteoarthritis in the hip was mediated by acetylarginine, specifically in four important metabolic pathways: ethanol degradation ( p = 0.044), amino sugar metabolism ( p = 0.090), fatty acid biosynthesis ( p = 0.095), and aspartate metabolism ( p = 0.097816). Conclusion There is a significant association between tryptophan levels and the risk of hip OA, as well as X-24757 levels and the risk of knee osteoarthritis. Additionally, X-24757 levels are also linked to the risk of hip OA. Moreover, this study has identified four crucial metabolic pathways in hip osteoarthritis, which are all regulated by acetylarginine. These findings provide valuable insights into potential biomarkers for OA and highlight potential pathways for its prevention and clinical intervention.

Differential Metabolites in Osteoarthritis: A Systematic Review and Meta-Analysis

Perturbations in Amino Acids and Metabolic Pathways in Osteoarthritis Patients Determined by Targeted Metabolomics Analysis.

Analysis of Serum Metabolomics in Rats with Osteoarthritis by Mass Spectrometry

Metabolomics in the development and progression of rheumatoid arthritis: A systematic review

Identification of Key Factors in Cartilage Tissue During the Progression of Osteoarthritis Using a Non-targeted Metabolomics Strategy

Metabolomic Analysis of Severe Osteoarthritis in a Spanish Population of Women Compared to Healthy and Osteoporotic Subjects

Metabolic profiling of synovial fluid in human temporomandibular joint osteoarthritis

Identification of polyunsaturated fatty acids as potential biomarkers of osteoarthritis after sodium hyaluronate and mesenchymal stem cell treatment through metabolomics

Causality of Genetically Determined Metabolites and Metabolic Pathways on Osteoarthritis: A Bi-Directional Two-Sample Mendelian Randomization Study

Identification of biomarkers related to tryptophan metabolism in osteoarthritis

Metabolomic Profiles and Pathways in Osteoarthritic Human Cartilage: A Comparative Analysis with Healthy Cartilage

Metabolomics of Synovial Fluid and Infrapatellar Fat Pad in Patients with Osteoarthritis or Rheumatoid Arthritis

Analysis of Gene Expression and Methylation Datasets Identified ADAMTS9, FKBP5, and PFKBF3 As Biomarkers for Osteoarthritis.

Classification of Osteoarthritis Phenotypes by Metabolomics Analysis

A comparative metabolomic analysis reveals the metabolic variations among cartilage of Kashin-Beck disease and osteoarthritis

Metabolomics in Osteoarthritis Knee: A Systematic Review of Literature

A Classification Modeling Approach for Determining Metabolite Signatures in Osteoarthritis

Blood and urine biomarkers for the diagnosis of early stages of knee osteoarthritis: A systematic review

Urinary Metabolomics As a Potentially Novel Diagnostic and Stratification Tool for Knee Osteoarthritis

Causal association of genetically determined plasma metabolites with osteoarthritis: a two-sample Mendelian randomization study

Serum Metabolome Analysis Identified Amino-Acid Metabolism Associated With Pain in People With Symptomatic Knee Osteoarthritis - A Cross-Sectional Study